Meeder Asset Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Meeder Asset Management's CDNA Position: Q2 2026 in Review
Meeder Asset Management reduced its CareDx (CDNA) stake by 90% in Q2 2026, selling an estimated $158K and leaving 830 shares worth $23.7K. The position accounts for ﹤0.01% of the portfolio, ranked #577.
Meeder Asset Management first reported a position in CDNA in Q3 2018 and has held it in 18 quarters since. The position peaked at $371K in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Meeder Asset Management held 830 shares of CareDx worth $23.7K as of Q2 2026.
- Meeder Asset Management sold 7,237 CareDx shares in Q2 2026, an estimated $158K.
- CareDx made up ﹤0.01% of Meeder Asset Management's portfolio in Q2 2026, its #577 holding.
- Meeder Asset Management first reported a position in CareDx in Q3 2018 and has held it in 18 quarters since.
- Meeder Asset Management's CareDx position peaked at $371K in Q2 2021.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.